Antares Pharma Profit Margin 2006-2019 | ATRS

Current and historical gross margin, operating margin and net profit margin for Antares Pharma (ATRS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Antares Pharma net profit margin as of June 30, 2019 is -4.03%.
Antares Pharma Annual Profit Margins
Antares Pharma Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.564B $0.064B
Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $68.595B 22.49
McKesson (MCK) United States $27.246B 10.52
AmerisourceBergen (ABC) United States $18.214B 12.52
Align Technology (ALGN) United States $16.776B 45.76
Laboratory Of America Holdings (LH) United States $16.418B 15.55
Cardinal Health (CAH) United States $14.740B 9.55
Cooper (COO) United States $14.244B 24.11
Straumann Holding AG (SAUHF) Switzerland $13.854B 0.00
DENTSPLY SIRONA (XRAY) United States $12.344B 26.09
West Pharmaceutical Services (WST) United States $10.331B 44.90
Henry Schein (HSIC) United States $9.326B 16.60
CONMED (CNMD) United States $2.765B 42.12
Merit Medical Systems (MMSI) United States $1.683B 17.53
Patterson (PDCO) United States $1.660B 12.32
Atrion (ATRI) United States $1.491B 41.49
STAAR Surgical (STAA) United States $1.257B 74.24
Lifevantage (LFVN) United States $0.207B 25.03
Invacare (IVC) United States $0.203B 0.00
Endologix (ELGX) United States $0.067B 0.00
Milestone Scientific (MLSS) United States $0.062B 0.00
Pro-Dex (PDEX) United States $0.057B 18.19
Retractable Technologies (RVP) United States $0.040B 0.00
Biolase (BIOL) United States $0.015B 0.00